Inflammatory markers in autoimmunity induced by checkpoint inhibitors
Husain B, Kirchberger M, Erdmann M, Schüpferling S, Abolhassani AR, Fröhlich W, Berking C, Heinzerling L (2021)
Publication Type: Journal article
Publication year: 2021
Journal
DOI: 10.1007/s00432-021-03550-5
Abstract
Purpose: Immune checkpoint inhibitors (ICI) are highly effective in several cancer entities, but also invoke a variety of immune-related adverse events (irAE). These are mostly reversible, but can be life-threatening or even fatal. Currently, the pathogenesis is not fully understood, but crucial for effective treatment. Prediction and early detection of irAE could be facilitated and treatment optimized if relevant biomarkers and effector mechanisms were better characterized. Methods: This study included a total of 45 irAE in patients with metastatic melanoma who were treated with ICI. All patients underwent a complete work-up with exclusion of other causes. Longitudinal blood samples were analyzed for a panel of soluble markers and compared to baseline and to patients who did not experience any irAE. Measurements included LDH, interleukin (IL)-6, IL-1β, IL-17, C-reactive protein (CRP) and tumor necrosis factor (TNF)-alpha as well as tumor markers S100 and melanoma inhibitory activity (MIA). Results: During the early onset of irAE increases in serum IL-6 (from mean 24.4 pg/ml at baseline to 51.0 pg/ml; p = 0.003) and CRP (from mean 7.0 mg/l at baseline to 17.7 mg/l; p = 0.001) and a decrease in MIA (from mean 5.4 pg/ml at baseline to 4.8 pg/ml; p = 0.035) were detected. No changes in IL-17 were noted. These effects were observed for irAE of different organ systems. Conclusion: Increases of a combination of IL-6 and CRP serum levels can be used for the early detection of irAE and tailored management. Interestingly, changes in MIA serum levels also correlate with irAE onset.
Authors with CRIS profile
Michael Kirchberger
Department of Dermatology
Carola Berking
Lehrstuhl für Haut- und Geschlechtskrankheiten
Lucie Heinzerling
Department of Dermatology
Involved external institutions
Germany (DE)How to cite
APA:
Husain, B., Kirchberger, M., Erdmann, M., Schüpferling, S., Abolhassani, A.R., Fröhlich, W.,... Heinzerling, L. (2021). Inflammatory markers in autoimmunity induced by checkpoint inhibitors. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-021-03550-5
MLA:
Husain, Beate, et al. "Inflammatory markers in autoimmunity induced by checkpoint inhibitors." Journal of Cancer Research and Clinical Oncology (2021).
BibTeX: Download